Meyka Pro banner
Graybug Vision, Inc.

Graybug Vision, Inc. (GRAY) Stock Overview

Explore Graybug Vision, Inc.’s financial performance, market position, analyst ratings, and future outlook.

GRAYNASDAQ
HealthcareBiotechnology
$5.50
$0.67(10.80%)
U.S. Market opens in 38h 33m

Graybug Vision, Inc. (GRAY)

Meyka AI Score

Z

Key Financials

Market Cap121M
P/E Ratio-4.23
EPS (TTM)$-20.63
ROE40.93%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

GRAY Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Graybug Vision, Inc. (NASDAQ: GRAY) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Graybug Vision, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of GRAY on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Graybug Vision, Inc.'s NASDAQ-traded stock include a P/E ratio of -4.23 and a market capitalization of 121M. Combined with our AI analysis, these give both institutional and retail investors a clear view of GRAY on the NASDAQ.

Price Performance (NASDAQ: GRAY)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
1150.00%
3-Month Change
707.64%
6-Month Change
467.01%
Year-to-Date (YTD) Change
864.91%
1-Year Change
366.10%
3-Year Change
-66.67%
5-Year Change
-66.67%
All-Time (Max) Change
-66.67%

Contact Information

650 487 2800
203 Redwood Shores Parkway, Redwood City, CA, 94065

Company Facts

80 Employees
IPO DateSep 4, 2020
CountryUS

Frequently Asked Questions